论文信息 - 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

[166] S. Cook,et al. Clinical use of temporary percutaneous left ventricular assist devices , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[167] D. Xavier,et al. High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. , 2011, Clinical biochemistry.

[168] Lawrence A Leiter,et al. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. , 2011, American heart journal.

[169] M. Tisminetzky,et al. Identifying Symptom Profiles of Depression and Anxiety in Patients with an Acute Coronary Syndrome Using Latent Class and Latent Transition Analysis , 2011, International journal of psychiatry in medicine.

[170] D. Atar,et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. , 2011, European heart journal.

[171] N. Weissman,et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. , 2011, The Journal of clinical endocrinology and metabolism.

[172] G. Schuler,et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.

[173] R. Twerenbold,et al. Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction , 2011 .

[174] Kevin Kennedy,et al. Appropriateness of percutaneous coronary intervention. , 2011, JAMA.

[175] W. Qiu,et al. Revascularization among patients with severe left ventricular dysfunction: a meta‐analysis of observational studies , 2011, European journal of heart failure.

[176] Michael B Nielsen,et al. Prognostic implications of nonobstructive coronary plaques in patients with non-ST-segment elevation myocardial infarction: a multidetector computed tomography study. , 2011, Journal of the American College of Cardiology.

[177] C. Lotan,et al. Bupropion for smoking cessation in patients with acute coronary syndrome. , 2011, Archives of internal medicine.

[178] C. Cannon,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial , 2011, BMJ : British Medical Journal.

[179] E. Antman,et al. Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel—Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) , 2011, Circulation.

[180] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[181] Shannon Marcoon,et al. Comparison of cardiac risk scores in ED patients with potential acute coronary syndrome. , 2011, Critical pathways in cardiology.

[182] S. Behar,et al. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes , 2011, Acute cardiac care.

[183] Alan S. Brown,et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2011, Circulation.

[184] A. Jaffe. The 10 commandments of troponin, with special reference to high sensitivity assays , 2011, Heart.

[185] R. Twerenbold,et al. B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain. , 2011, The American journal of medicine.

[186] Simon Dixon,et al. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial. , 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[187] P. Ho,et al. Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®). , 2011, American heart journal.

[188] C. Cannon,et al. Benefit of Intensive Statin Therapy in Women: Results From PROVE IT-TIMI 22 , 2011, Circulation. Cardiovascular quality and outcomes.

[189] Denis Xavier,et al. Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[190] K. Gadde,et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial , 2011, The Lancet.

[191] G. Guyatt,et al. Prognostic Value of Troponin and Creatine Kinase Muscle and Brain Isoenzyme Measurement after Noncardiac Surgery: A Systematic Review and Meta-analysis , 2011, Anesthesiology.

[192] R. Twerenbold,et al. The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide , 2011, Heart.

[193] C. Reid,et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study , 2011, The Lancet.

[194] Rowena J Dolor,et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. , 2011, Journal of the American College of Cardiology.

[195] R. Body,et al. Low soluble P-selectin may facilitate early exclusion of acute myocardial infarction. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[196] N. Schork,et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. , 2011, JAMA.

[197] G. Stone,et al. Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial). , 2011, The American journal of cardiology.

[198] J. Gurwitz,et al. Exclusion of Older Adults and Women from Recent Trials of Acute Coronary Syndromes , 2011, Journal of the American Geriatrics Society.

[199] M. Pfisterer,et al. Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials , 2011, Acute cardiac care.

[200] M. van’t Veer,et al. Rapid detection of myocardial infarction with a sensitive troponin test. , 2011, American journal of clinical pathology.

[201] M. Sabatine,et al. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. , 2011, European heart journal.

[202] S. Petersen,et al. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. , 2011, Journal of the American College of Cardiology.

[203] C. Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. , 2011, Journal of the American College of Cardiology.

[204] R. Lange,et al. Twenty years of cardiac surgery in patients aged 80 years and older: risks and benefits. , 2011, The Annals of thoracic surgery.

[205] S. Steinhubl,et al. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. , 2011, American heart journal.

[206] H. White,et al. Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. , 2011, American heart journal.

[207] O. Morel,et al. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. , 2011, Journal of the American College of Cardiology.

[208] A. Jaffe,et al. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[209] Gregory Y H Lip,et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. , 2011, Journal of the American College of Cardiology.

[210] K. Goel,et al. Impact of Cardiac Rehabilitation on Mortality and Cardiovascular Events After Percutaneous Coronary Intervention in the Community , 2010, Circulation.

[211] C. Heeschen,et al. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome , 2010, Heart.

[212] P. Mody,et al. Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient , 2011 .

[213] P. Libby,et al. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features , 2011 .

[214] S. Werns. Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes , 2011 .

[215] L. Rohde,et al. II Guidelines for perioperative evaluation of the Brazilian Society of Cardiology. , 2011, Arquivos brasileiros de cardiologia.

[216] Gen-Min Lin,et al. Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty. , 2011, The American journal of cardiology.

[217] H. Kishida,et al. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. , 2011, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[218] Laura A. Levit,et al. Finding what works in health care : standards for systematic reviews , 2011 .

[219] S. Greenfield,et al. COMMITTEE ON STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES , 2011 .

[220] S. Steinhubl,et al. Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy , 2011, Journal of Thrombosis and Thrombolysis.

[221] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.

[222] A. Khera,et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[223] Deepak L. Bhatt,et al. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). , 2010, American heart journal.

[224] V. Figueredo,et al. As submitted to : Coronary Artery Disease And later published as : “ Incidence of , Predictors for , and Mortality Associated with Malignant Ventricular Arrhythmias in Non-ST Elevation Myocardial Infarction Patients , 2017 .

[225] Sunil V. Rao,et al. Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with , 2010, American heart journal.

[226] Charles J. Kahi,et al. ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use , 2010, The American Journal of Gastroenterology.

[227] P. Galan,et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial , 2010, BMJ : British Medical Journal.

[228] C. Cannon,et al. What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?: Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial , 2010, Circulation.

[229] Stephen Balter,et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. , 2010, JAMA.

[230] Davide Capodanno,et al. Antithrombotic therapy in the elderly. , 2010, Journal of the American College of Cardiology.

[231] K. Eagle,et al. Comparison of baseline characteristics, management and outcome of patients with non-ST-segment elevation acute coronary syndrome in versus not in clinical trials. , 2010, The American journal of cardiology.

[232] A. Yan,et al. Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring. , 2010, The American journal of cardiology.

[233] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[234] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[235] Deepak L. Bhatt,et al. Clopidogrel with or without omeprazole in coronary artery disease. , 2010, The New England journal of medicine.

[236] E. DeLong,et al. Delay from symptom onset to hospital presentation for patients with non-ST-segment elevation myocardial infarction. , 2010, Archives of internal medicine.

[237] R. Neumar,et al. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[238] H. Bueno,et al. "Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?". , 2010, American heart journal.

[239] L. Newby,et al. Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry. , 2010, American heart journal.

[240] J. Messenger,et al. Association of prior coronary artery bypass graft surgery with quality of care of patients with non-ST-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines. , 2010, American heart journal.

[241] B. Lindahl,et al. Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I. , 2010, American heart journal.

[242] James McCord,et al. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. , 2010, Circulation.

[243] E. Antman,et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis , 2010, The Lancet.

[244] S. Yusuf,et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial , 2010, The Lancet.

[245] S. Reis,et al. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, JACC. Cardiovascular imaging.

[246] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[247] F. Nogueira,et al. B-type natriuretic peptide is predictive of postoperative events in orthopedic surgery. , 2010, Arquivos brasileiros de cardiologia.

[248] Sunil V. Rao,et al. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. , 2010, JAMA.

[249] L. Sinoway,et al. Revisiting the role of oxygen therapy in cardiac patients. , 2010, Journal of the American College of Cardiology.

[250] M. Keltai,et al. Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial , 2010 .

[251] Fredrik Folke,et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.

[252] Deepak L. Bhatt,et al. Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. , 2010, The American journal of cardiology.

[253] K. Eagle,et al. Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry , 2010, Coronary artery disease.

[254] P. Doevendans,et al. Chest pain in the emergency room: a multicenter validation of the HEART Score. , 2010, Critical pathways in cardiology.

[255] J. Tijssen,et al. Prediction of 1-Year Mortality With Different Measures of ST-Segment Recovery in All-Comers After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction , 2010, Circulation. Cardiovascular quality and outcomes.

[256] Harlan M Krumholz,et al. National Patterns of Risk-Standardized Mortality and Readmission for Acute Myocardial Infarction and Heart Failure: Update on Publicly Reported Outcomes Measures Based on the 2010 Release , 2010, Circulation. Cardiovascular quality and outcomes.

[257] Mario Plebani,et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[258] S. Stevens,et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial , 2010, European heart journal.

[259] R. Stables,et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. , 2010, JAMA.

[260] Harlan M Krumholz,et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. , 2010, Journal of the American College of Cardiology.

[261] K. Huber,et al. Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis , 2010, Heart.

[262] W. Matthai. Evaluation of thrombocytopenia in the acute coronary syndrome , 2010, Current opinion in hematology.

[263] B. Lindahl,et al. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. , 2010, American heart journal.

[264] T. Akasaka,et al. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[265] S. Kaul,et al. ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association , 2010, Circulation.

[266] G. Bakris,et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.

[267] L. Wallentin,et al. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers. , 2010, American heart journal.

[268] Sonia S Anand,et al. Identifying women with severe angiographic coronary disease , 2010, Journal of internal medicine.

[269] M. Mack,et al. Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2010, Circulation.

[270] S. Pocock,et al. A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[271] A. Hall,et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. , 2010, Journal of the American College of Cardiology.

[272] S. Pocock,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.

[273] T. Carey,et al. Three-year outcomes of multivessel revascularization in very elderly acute coronary syndrome patients. , 2010, The Annals of thoracic surgery.

[274] O. Simonetti,et al. Cardiac magnetic resonance with edema imaging identifies myocardium at risk and predicts worse outcome in patients with non-ST-segment elevation acute coronary syndrome. , 2010, Journal of the American College of Cardiology.

[275] P. Kirchhof,et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a , 2010, European heart journal.

[276] E. Vittinghoff,et al. Beta-blockers for chest pain associated with recent cocaine use. , 2010, Archives of internal medicine.

[277] Sohail Q Khan,et al. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP , 2010, Heart.

[278] D. Stott,et al. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. , 2010, Journal of the American College of Cardiology.

[279] M. Sabatine,et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. , 2010, Journal of the American College of Cardiology.

[280] S. Blankenberg,et al. Copeptin improves early diagnosis of acute myocardial infarction. , 2010, Journal of the American College of Cardiology.

[281] R. Califf,et al. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[282] R. Chintala,et al. Spontaneous coronary artery dissection: aggressive vs. conservative therapy. , 2010, The Journal of invasive cardiology.

[283] J. Mega,et al. Clinical Features and Outcomes of Women With Unstable Ischemic Heart Disease: Observations From Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndromes–Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) , 2010, Circulation.

[284] D. Faxon,et al. Coronary Intervention in Patients With Acute Coronary Syndrome: Does Every Culprit Lesion Require Revascularization? , 2010, Current cardiology reports.

[285] V. Boyko,et al. Effect of narcotic treatment on outcomes of acute coronary syndromes. , 2010, The American journal of cardiology.

[286] Richard Body,et al. Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome. , 2010, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[287] F. Biancari,et al. Coronary artery bypass surgery in octogenarians: long-term outcome can be better than expected. , 2010, The Annals of thoracic surgery.

[288] E. Ohman,et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). , 2010, JACC. Cardiovascular interventions.

[289] H. Katus,et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. , 2010, Clinical chemistry.

[290] J. Vincent,et al. Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[291] R. Califf,et al. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. , 2010, International journal of cardiology.

[292] P. Damman,et al. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. , 2010, Journal of the American College of Cardiology.

[293] A. Moss,et al. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction. , 2010, American Journal of Cardiology.

[294] Yasuo Ohashi,et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.

[295] S. Yusuf,et al. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[296] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.

[297] E. Amsterdam,et al. Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program). , 2010, The American journal of cardiology.

[298] K. Buth,et al. Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. , 2010, The Annals of thoracic surgery.

[299] J. Gore,et al. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. , 2010, European heart journal.

[300] C. Pedone,et al. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. , 2010, Current medicinal chemistry.

[301] K. Alexander,et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.

[302] Barry J Maron,et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[303] K. Schulman,et al. Relationship Between Cardiac Rehabilitation and Long-Term Risks of Death and Myocardial Infarction Among Elderly Medicare Beneficiaries , 2010, Circulation.

[304] R. Koppensteiner,et al. Adenosine diphosphate‐inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel , 2010, Journal of thrombosis and haemostasis : JTH.

[305] P. Kirchhof,et al. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting , 2009, Thrombosis and Haemostasis.

[306] L. Halasyamani,et al. Preferred Practices and Performance Measures for Measuring and Reporting Care Coordination: A Consensus Report , 2010 .

[307] B. Gersh. Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]) , 2010 .

[308] R. Suri. Outcomes Following Pre-Operative Clopidogrel Administration in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial , 2010 .

[309] Jeffrey L. Anderson,et al. ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults , 2010 .

[310] C. Whitney,et al. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). , 2010, MMWR. Morbidity and mortality weekly report.

[311] N. Toma. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of Ticagrelor versus Clopidogrel in patients with stable coronary artery disease. The ONSET/OFFSET study. , 2010, Maedica.

[312] M. Elbaz,et al. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department. , 2010, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[313] I. Piña,et al. AACVPR/ACCF/AHA 2010 Update: Performance Measures on Cardiac Rehabilitation for Referral to Cardiac Rehabilitation/Secondary Prevention Services Endorsed by the American College of Chest Physicians, the American College of Sports Medicine, the American Physical Therapy Association, the Canadian Asso , 2010, Journal of the American College of Cardiology.

[314] I. Scott,et al. Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. , 2010, The Cochrane database of systematic reviews.

[315] Michael Marber,et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction , 2010 .

[316] E. Topol,et al. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. , 2010, European heart journal.

[317] D. Wagner,et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. , 2009, Journal of the American College of Cardiology.

[318] Tobias Reichlin,et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[319] R. Califf,et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.

[320] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[321] S. Yusuf,et al. Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[322] P. Clemmensen,et al. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome. , 2009, The American journal of cardiology.

[323] R. Giugliano,et al. Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-P , 2009, The Canadian journal of cardiology.

[324] M. Rosner,et al. Acute kidney injury. , 2009, Current drug targets.

[325] H. Calkins,et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. , 2009, Journal of the American College of Cardiology.

[326] Mark J. Antonino,et al. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease: The ONSET/OFFSET Study , 2009, Circulation.

[327] G. Stone,et al. Abstract 4949: Bleeding and Ischemic Complications in Patients With Acute Coronary Syndromes and Chronic Kidney Disease in Relation to Different Glycoprotein IIb/IIIa Inhibitors: Analysis From the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) Trial , 2009 .

[328] S. Steinhubl,et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. , 2009, JACC. Cardiovascular interventions.

[329] Sang Hyun Park,et al. A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure. , 2009, The American journal of cardiology.

[330] K. Anstrom,et al. Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). , 2009, The American journal of cardiology.

[331] M. A. Soliman Hamad,et al. Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[332] Sean M. O'Brien,et al. Reoperation for Bleeding in Patients Undergoing Coronary Artery Bypass Surgery: Incidence, Risk Factors, Time Trends, and Outcomes , 2009, Circulation. Cardiovascular quality and outcomes.

[333] C. Noel Bairey Merz,et al. Women and ischemic heart disease: evolving knowledge. , 2009, Journal of the American College of Cardiology.

[334] R. Peters,et al. A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure. , 2009, The Netherlands journal of medicine.

[335] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.

[336] L. Wallentin,et al. Influence of Renal Function on the Effects of Early Revascularization in Non–ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009, Circulation.

[337] Michele Voeltz,et al. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. , 2009, The American journal of cardiology.

[338] S. Manoukian. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. , 2009, The American journal of cardiology.

[339] E. Vicaut,et al. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. , 2009, JAMA.

[340] G. Lemesle,et al. Impact of bivalirudin on in‐hospital bleeding and six‐month outcomes in octogenarians undergoing percutaneous coronary intervention , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[341] W. Gibler,et al. The Usage Patterns of Cardiac Bedside Markers Employing Point‐of‐Care Testing for Troponin in Non‐ST‐Segment Elevation Acute Coronary Syndrome: Results from CRUSADE , 2009, Clinical cardiology.

[342] P. Serruys,et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. , 2009, European heart journal.

[343] M. Weatherall,et al. Systematic review of studies of the effect of hyperoxia on coronary blood flow. , 2009, American heart journal.

[344] M. Desai,et al. Statistical Models and Patient Predictors of Readmission for Acute Myocardial Infarction: A Systematic Review , 2009, Circulation. Cardiovascular quality and outcomes.

[345] J. O’Connell,et al. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. , 2009, JAMA.

[346] E. Antman,et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis , 2009, Journal of the American College of Cardiology.

[347] G. De Luca,et al. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty , 2009, Thrombosis and Haemostasis.

[348] E. Paolasso,et al. Culprit-only or multivessel percutaneous coronary stenting in patients with non-ST-segment elevation acute coronary syndromes: one-year follow-up. , 2009, Journal of interventional cardiology.

[349] P. Armstrong,et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. , 2009, European heart journal.

[350] L. Wallentin,et al. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. , 2009, Journal of the American College of Cardiology.

[351] K. Anstrom,et al. Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin. , 2009, The American journal of cardiology.

[352] S. Normand,et al. Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.

[353] S. Normand,et al. Cardiac rehabilitation and survival in older coronary patients. , 2009, Journal of the American College of Cardiology.

[354] E. Burgess,et al. Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial , 2009, Canadian Medical Association Journal.

[355] M. Ohlow,et al. Incidence and outcome of femoral vascular complications among 18,165 patients undergoing cardiac catheterisation. , 2009, International journal of cardiology.

[356] Deepak L. Bhatt,et al. Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial , 2009, Circulation.

[357] C. Weston,et al. Determinants and outcomes of coronary angiography after non-ST-segment elevation myocardial infarction. A cohort study of the Myocardial Ischaemia National Audit Project (MINAP) , 2009, Heart.

[358] J. Ware,et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. , 2009, European heart journal.

[359] J. Gore,et al. Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. , 2009, The American journal of cardiology.

[360] E. Braunwald,et al. Early angiography in patients with chronic kidney disease: a collaborative systematic review. , 2009, American Society of Nephrology. Clinical Journal.

[361] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[362] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[363] W. Gibler,et al. Incidence and Prognostic Significance of Thrombocytopenia Developed During Acute Coronary Syndrome in Contemporary Clinical Practice , 2009, Circulation.

[364] A. D. de Luna,et al. Coronary Artery Spasm: A 2009 Update , 2009, Circulation.

[365] Carl J Pepine,et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.

[366] Fabian Bamberg,et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. , 2009, Journal of the American College of Cardiology.

[367] K. Alexander,et al. Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). , 2009, The American journal of cardiology.

[368] S. Saba,et al. Location of Acute Myocardial Infarction and Associated Arrhythmias and Outcome , 2009, Clinical cardiology.

[369] F. Apple,et al. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. , 2009, Clinical chemistry.

[370] E. Braunwald,et al. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. , 2009, Journal of the American College of Cardiology.

[371] J. Denollet,et al. The Association of Cognitive and Somatic Depressive Symptoms With Depression Recognition and Outcomes After Myocardial Infarction , 2009, Circulation. Cardiovascular quality and outcomes.

[372] Sunil V. Rao,et al. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score , 2009, Circulation.

[373] S. Pocock,et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[374] Mark V. Williams,et al. Transitions of Care Consensus Policy Statement American College of Physicians-Society of General Internal Medicine-Society of Hospital Medicine-American Geriatrics Society-American College of Emergency Physicians-Society of Academic Emergency Medicine , 2009, Journal of General Internal Medicine.

[375] P. Libby,et al. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. , 2009, American heart journal.

[376] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[377] B. Gersh,et al. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2009, Journal of the American College of Cardiology.

[378] Deepak L. Bhatt,et al. Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding , 2009, Annals of Internal Medicine.

[379] H. Bueno,et al. Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. , 2009, The American journal of cardiology.

[380] Insung Chung,et al. Faculty Opinions recommendation of Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction , 2009 .

[381] E. Antman,et al. Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction , 2009, Circulation.

[382] L. Lind,et al. Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? , 2009, The American journal of cardiology.

[383] W. Gibler,et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial. , 2009, Annals of emergency medicine.

[384] Á. Avezum,et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. , 2009, Archives of internal medicine.

[385] Stephen A. Martin,et al. A Reengineered Hospital Discharge Program to Decrease Rehospitalization , 2009, Annals of Internal Medicine.

[386] E. Douglass. The Obesity Paradox in Non-ST Segment Elevation Acute Coronary Syndromes: Results from the Rapid Risk Stratification of Unstable Angina Patients Can Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Ini , 2009 .

[387] C. Reid,et al. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. , 2009, JACC. Cardiovascular interventions.

[388] M. Imasa,et al. Folic Acid-Based Intervention in Non-ST Elevation Acute Coronary Syndromes , 2009, Asian cardiovascular & thoracic annals.

[389] Jennifer G. Robinson,et al. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. , 2009, Journal of the American College of Cardiology.

[390] Betti Giusti,et al. Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay: A 12-Month Follow-Up , 2009, Circulation.

[391] C. Aydin,et al. Cardiac troponin levels in pregnant women with severe pre-eclampsia , 2009, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[392] G. Lip,et al. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. , 2008, European heart journal.

[393] S. Yusuf,et al. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. , 2008, European heart journal.

[394] M. Sabatine,et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. , 2008, European heart journal.

[395] Brian T. Austin,et al. Evidence on the Chronic Care Model in the new millennium. , 2009, Health affairs.

[396] M. Roe,et al. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). , 2009, American heart journal.

[397] Claudia Stöllberger,et al. Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[398] I. Palacios,et al. Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction , 2008, Circulation.

[399] D. Goldstein,et al. Takotsubo Cardiomyopathy: A New Form of Acute, Reversible Heart Failure , 2008, Circulation.

[400] A. Gavazzi,et al. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. , 2008, The American journal of cardiology.

[401] J. Gore,et al. Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation. , 2008, The American journal of cardiology.

[402] Elizabeth DeLong,et al. ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2008, Journal of the American College of Cardiology.

[403] Jeremiah R. Brown,et al. Interaction of gender and age on post cardiac catheterization contrast-induced acute kidney injury. , 2008, American Journal of Cardiology.

[404] Bernie Smith,et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. , 2008, European heart journal.

[405] S. Topal,et al. Gemcitabine-Induced Acute Coronary Syndrome: A Case Report , 2008, Medical Principles and Practice.

[406] S. Steinhubl,et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. , 2008, Journal of the American College of Cardiology.

[407] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.

[408] C. Meisinger,et al. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA , 2008, The American journal of cardiology.

[409] D. Mark,et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. , 2008, American heart journal.

[410] A. Kastrati,et al. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation , 2008, Journal of internal medicine.

[411] K. Schindler,et al. Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. , 2008, European heart journal.

[412] T. Sundt,et al. Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis , 2008, Nature Clinical Practice Cardiovascular Medicine.

[413] E. Antman,et al. Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 , 2008, Circulation.

[414] Viola Vaccarino,et al. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. , 2008, Archives of internal medicine.

[415] Marcus R. Munafo,et al. Smoking cessation interventions for hospitalized smokers: a systematic review. , 2008, Archives of internal medicine.

[416] Takeshi Kimura,et al. Long-Term Outcomes of Coronary-Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease in the Bare-Metal Stent Era , 2008, Circulation.

[417] J Thomas Bigger,et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.

[418] S. Yusuf,et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2008, The Lancet.

[419] C. Macaya,et al. Anemia. Infarto de miocardio. Influence of Hemoglobin Level on In-Hospital Prognosis in Patients With Acute Coronary Syndrome. , 2008, Revista espanola de cardiologia.

[420] R. Califf,et al. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). , 2008, The American journal of cardiology.

[421] A. Kastrati,et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. , 2008, The New England journal of medicine.

[422] Y. Honda,et al. Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction: a novel predictor of prognosis after acute myocardial infarction. , 2008, Journal of the American College of Cardiology.

[423] U. Sechtem,et al. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. , 2008, Journal of the American College of Cardiology.

[424] K. Alexander,et al. Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.

[425] Fang-Shu Ou,et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. , 2008, JACC. Cardiovascular interventions.

[426] K. Bybee,et al. Stress-Related Cardiomyopathy Syndromes , 2008, Circulation.

[427] M. Sabatine,et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.

[428] Arthur N Westover,et al. Acute myocardial infarction in young adults who abuse amphetamines. , 2008, Drug and alcohol dependence.

[429] F. Lau,et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. , 2008, Annals of emergency medicine.

[430] A. Hirayama,et al. Treatment of Coronary Spastic Angina With a Statin in Addition to a Calcium Channel Blocker: A Pilot Study , 2008, Journal of cardiovascular pharmacology.

[431] J. Mega,et al. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[432] G. Dagenais,et al. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. , 2008, Journal of the American College of Cardiology.

[433] J. Hirsh,et al. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[434] R. Beyth,et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[435] Sunil V. Rao,et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.

[436] Denis Xavier,et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[437] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[438] B. Gersh,et al. Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.

[439] K. Eagle,et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events , 2008, Heart.

[440] M. Horie,et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. , 2008, Journal of the American College of Cardiology.

[441] N. Yang,et al. Role of Coronary Spasm for a Positive Noninvasive Stress Test Result in Angina Pectoris Patients Without Hemodynamically Significant Coronary Artery Disease , 2008, The American journal of the medical sciences.

[442] G. Stone,et al. Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2008, Journal of the American College of Cardiology.

[443] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[444] B. Drew,et al. A Scientific Statement From the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology , 2008 .

[445] M. Pfeffer,et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. , 2008, American heart journal.

[446] M. Niemelä,et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. , 2008, European heart journal.

[447] C. Hamm,et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. , 2008, Journal of the American College of Cardiology.

[448] W. Peacock,et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis , 2008, Emergency Medicine Journal.

[449] K. Alexander,et al. Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[450] J D Hilton,et al. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) , 2008, Heart.

[451] C. Meuleman. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. The ONTARGET Investigators. , 2008 .

[452] R. Pannu,et al. Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials. , 2008, Critical pathways in cardiology.

[453] H. Shimokawa,et al. Prognostic Effects of Benidipine in Patients With Vasospastic Angina: Comparison With Diltiazem and Amlodipine , 2008, Journal of cardiovascular pharmacology.

[454] A. Lerman,et al. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. , 2008, American heart journal.

[455] J. Hollander. Cocaine intoxication and hypertension. , 2008, Annals of emergency medicine.

[456] Thomas E. Moritz,et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. , 2008, European heart journal.

[457] S. Hailpern,et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. , 2008, Annals of emergency medicine.

[458] A. Jaffe,et al. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. , 2008, Journal of the American College of Cardiology.

[459] J. Trickett,et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. , 2008, The New England journal of medicine.

[460] K. Anstrom,et al. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. , 2008, Archives of internal medicine.

[461] Á. Avezum,et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. , 2007, European heart journal.

[462] William Wijns,et al. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[463] Harlan M. Krumholz,et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Eleva , 2006, Journal of the American College of Cardiology.

[464] E. Antman,et al. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis , 2008, Journal of Thrombosis and Thrombolysis.

[465] Deepak L. Bhatt,et al. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. , 2008, American heart journal.

[466] I. Stiell,et al. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis. , 2008, CJEM.

[467] A. Oto,et al. Thrombocytopenia Associated with Antithrombotic Therapy in Patients with Cardiovascular Diseases , 2008, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[468] Sanjay Kaul,et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2008, Journal of the American College of Cardiology.

[469] C. Macaya,et al. Influence of hemoglobin level on in-hospital prognosis in patients with acute coronary syndrome. , 2008, Revista espanola de cardiologia.

[470] R. Beyth,et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[471] R. Califf,et al. Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial , 2008, Journal of General Internal Medicine.

[472] E. Antman,et al. Prasugrel Compared With High Loading– and Maintenance–Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial , 2007, Circulation.

[473] E. Antman,et al. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. , 2007, The American journal of cardiology.

[474] J. Gore,et al. Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? , 2007, Circulation.

[475] T. Ryan,et al. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease. , 2007, The Annals of thoracic surgery.

[476] E. Amsterdam,et al. Evaluation of patients with methamphetamine- and cocaine-related chest pain in a chest pain observation unit. , 2007, Critical pathways in cardiology.

[477] A. Kirtane,et al. Gender-specific outcomes after sirolimus-eluting stent implantation. , 2007, Journal of the American College of Cardiology.

[478] A. Hall,et al. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. , 2007, Journal of the American College of Cardiology.

[479] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[480] P. Armstrong,et al. Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes , 2007, Canadian Medical Association Journal.

[481] S. Yusuf,et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. , 2007, Journal of the American College of Cardiology.

[482] I. Piña,et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Associati , 2007, Journal of the American College of Cardiology.

[483] A. Siegbahn,et al. Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome , 2007, Circulation.

[484] Sociedade Brasileira de Cardiologia. [Guidelines for Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction of the Brazilian Society of Cardiology (II Edition,2007)]. , 2007, Arquivos brasileiros de cardiologia.

[485] K. Eagle,et al. A Systematic Review of Gender Differences in Mortality after Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions , 2007, Clinical cardiology.

[486] I. Piña,et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. , 2007, Journal of cardiopulmonary rehabilitation and prevention.

[487] Á. Avezum,et al. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl. , 2007, The American journal of cardiology.

[488] S. Yusuf,et al. Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in NonST-Segment Elevation Acute Coronary Syndromes , 2007, Annals of Internal Medicine.

[489] R. Mestril,et al. Troponin I levels in patients with preeclampsia. , 2007, The American journal of medicine.

[490] I. Piña,et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. , 2007, Circulation.

[491] K. Seung,et al. Clinical and angiographic characteristics of acute myocardial infarction caused by vasospastic angina without organic coronary heart disease. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[492] W. Laskey,et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. , 2007, Journal of the American College of Cardiology.

[493] Timothy D. Henry,et al. A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction , 2007, Circulation.

[494] J. Ornato,et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.

[495] W. Gibler,et al. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. , 2007, The American journal of medicine.

[496] A. Lerman,et al. Four-year recurrence rate and prognosis of the apical ballooning syndrome. , 2007, Journal of the American College of Cardiology.

[497] K. Alexander,et al. Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. , 2007, Archives of internal medicine.

[498] A. Einstein,et al. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. , 2007, JAMA.

[499] S. Steinhubl,et al. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. , 2007, American heart journal.

[500] D. Caesar,et al. Chest pain presenting to the Emergency Department--to stratify risk with GRACE or TIMI? , 2007, Resuscitation.

[501] P. Erne,et al. Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry , 2007, Heart.

[502] Lefeng Wang,et al. [Effects of intracoronary or intravenous tirofiban administration in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention]. , 2007, Zhonghua xin xue guan bing za zhi.

[503] Vera Bittner,et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Pr , 2007, Circulation.

[504] F. Crea,et al. Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. , 2007, International journal of cardiology.

[505] M. Naylor,et al. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[506] Matthew W. Martinez,et al. Myocardial infarction with normal coronary arteries: a role for MRI? , 2007, Clinical chemistry.

[507] F. Di Serio,et al. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department , 2007, Coronary artery disease.

[508] A. Jaffe,et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[509] R. Califf,et al. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. , 2007, European heart journal.

[510] D. Pennell,et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. , 2007, European heart journal.

[511] Timothy J Gardner,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Circulation.

[512] A. Skene,et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. , 2007, JAMA.

[513] F. Van de Werf,et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. , 2007, JAMA.

[514] A. Jaffe,et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. , 2007, Clinical chemistry.

[515] Jack P. Chen. Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm. , 2007, The Journal of invasive cardiology.

[516] E. Antman,et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. , 2007, Circulation.

[517] Rowena J Dolor,et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.

[518] J. Ware,et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial , 2007, The Lancet.

[519] H. Krumholz,et al. Financial barriers to health care and outcomes after acute myocardial infarction. , 2007, JAMA.

[520] Christian Gluud,et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. , 2007, JAMA.

[521] Deepak L. Bhatt,et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? , 2007, Journal of the American College of Cardiology.

[522] J. Ware,et al. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. , 2007, JAMA.

[523] Ji-nan Zhang,et al. Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome. , 2007, International journal of cardiology.

[524] C. Grines,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[525] R. Califf,et al. The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. , 2007, European heart journal.

[526] J. Hollander,et al. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. , 2007, Annals of emergency medicine.

[527] S. Mohiuddin,et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. , 2007, Chest.

[528] S. Normand,et al. Socioeconomic disparities in outcomes after acute myocardial infarction. , 2007, American heart journal.

[529] M. Oz,et al. Discharge to home rates are significantly lower for octogenarians undergoing coronary artery bypass graft surgery. , 2007, The Annals of thoracic surgery.

[530] D. Atar,et al. Assessment of bleeding events in clinical trials--proposal of a new classification. , 2007, The American journal of cardiology.

[531] S. Grundy,et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2006, Diabetes Care.

[532] S. Plein,et al. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction , 2006, Heart.

[533] F. Van de Werf,et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) , 2005, Heart.

[534] John B. Wong,et al. Detecting acute cardiac ischemia in the emergency department , 1990, Journal of General Internal Medicine.

[535] G. Gravlee. Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery , 2007 .

[536] M. Naylor,et al. Collaboration With the Society of Geriatric Cardiology In the American Heart Association Council on Clinical Cardiology: Coronary Syndromes: A Scientific Statement for Healthcare Professionals From Acute Coronary Care in the Elderly, Part I: Non-ST-Segment-Elevation Acute , 2007 .

[537] L. Shaw,et al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[538] W. Gibler,et al. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. , 2006, Annals of emergency medicine.

[539] D. Singer,et al. Bupropion for smokers hospitalized with acute cardiovascular disease. , 2006, The American journal of medicine.

[540] R. Califf,et al. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibi , 2006, American heart journal.

[541] M. Dong,et al. Alteration and significance of serum cardiac troponin I and cystatin C in preeclampsia. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[542] K. Eagle,et al. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events. , 2006, American heart journal.

[543] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.

[544] A. Jaffe. Chasing troponin: how low can you go if you can see the rise? , 2006, Journal of the American College of Cardiology.

[545] P. McGettigan,et al. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. , 2006, JAMA.

[546] Deepak L. Bhatt,et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. , 2006, Journal of the American College of Cardiology.

[547] A. Adesanya,et al. A COMPARISON OF PATIENT STATE INDEX, BISPECTRAL INDEX, AND MODIFIED RAMSAY SEDATION SCORES IN MECHANICALLY VENTILATED CRITICALLY ILL PATIENTS , 2006 .

[548] R. Califf,et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. , 2006, The Annals of thoracic surgery.

[549] J. Blankenship,et al. Non-ST segment elevation acute coronary syndromes. , 2006, Southern medical journal.

[550] K. Alexander,et al. Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors: Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative , 2006, Circulation.

[551] Sung-joon Min,et al. The care transitions intervention: results of a randomized controlled trial. , 2006, Archives of internal medicine.

[552] T. Villines,et al. The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[553] R. Califf,et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. , 2006, Journal of the American College of Cardiology.

[554] C. Meuleman. Benefit of early invasive therapy in acute coronary syndromes. A meta-analysis of contemporary randomized clinical trials. , 2006 .

[555] Dan M. Roden,et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[556] D. Burkhoff,et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.

[557] Maureen Chase,et al. Prospective validation of the Thrombolysis in Myocardial Infarction Risk Score in the emergency department chest pain population. , 2006, Annals of emergency medicine.

[558] T. Harris,et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. , 2006, The New England journal of medicine.

[559] Sun Ha Jee,et al. Body-mass index and mortality in Korean men and women. , 2006, The New England journal of medicine.

[560] H. Tunstall-Pedoe,et al. Redefinition of Myocardial Infarction: Prospective Evaluation in the Community , 2006, Circulation.

[561] V. Montori,et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies , 2006, The Lancet.

[562] B. Strauss,et al. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries). , 2006, The American journal of cardiology.

[563] S. Yusuf,et al. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials , 2006, The Lancet.

[564] Christopher P Cannon,et al. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. , 2006, Journal of the American College of Cardiology.

[565] J. D. de Lemos,et al. Management of perioperative myocardial infarction in noncardiac surgical patients. , 2006, Chest.

[566] C. Cannon,et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. , 2006, Journal of the American College of Cardiology.

[567] S. Yusuf,et al. Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study , 2006, Circulation.

[568] S. Tonstad,et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.

[569] Peter A Kavsak,et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. , 2006, American heart journal.

[570] W. Gibler,et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Ini , 2006, American heart journal.

[571] L. Køber,et al. Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction , 2006, Circulation.

[572] G. Mancia,et al. Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? , 2006, Annals of Internal Medicine.

[573] A. Jaffe,et al. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. , 2006, International journal of cardiology.

[574] A Darzi,et al. Early outcomes in the elderly: a meta-analysis of 4921 patients undergoing coronary artery bypass grafting—comparison between off-pump and on-pump techniques , 2006, Heart.

[575] H. White,et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.

[576] J. Emberson,et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials , 2006, BMJ : British Medical Journal.

[577] E. Topol,et al. Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. , 2006, The American journal of cardiology.

[578] B. Chaitman. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. , 2006, Circulation.

[579] B. Lewis,et al. Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography. , 2006, The American journal of cardiology.

[580] P. Fitzgerald,et al. Location of focal vasospasm provoked by ergonovine maleate within coronary arteries in patients with vasospastic angina pectoris. , 2006, The American journal of cardiology.

[581] A. Jaffe,et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. , 2006, Clinical chemistry.

[582] Elizabeth R DeLong,et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. , 2006, JAMA.

[583] Per Magne Ueland,et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[584] P. Steg,et al. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. , 2006, Archives of internal medicine.

[585] J. Cox,et al. Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes , 2006, Cardiovascular diabetology.

[586] Salim Yusuf,et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.

[587] S. Yusuf,et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.

[588] A. Kastrati,et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. , 2006, JAMA.

[589] J. Christiansen,et al. Detection of myocardial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. , 2006, The American journal of cardiology.

[590] K. Chandrasekaran,et al. Transient cardiac apical ballooning syndrome: prevalence and clinical implications of right ventricular involvement. , 2006, Journal of the American College of Cardiology.

[591] K. Eagle,et al. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). , 2006, American heart journal.

[592] Lippincott Williams Wilkins,et al. ACC/AHA/SCAI Practice Guidelines, February 21, 2006 , 2006 .

[593] Matthias Briel,et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[594] P. Armstrong,et al. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial , 2006, The Lancet.

[595] L. Newby,et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. , 2006, Journal of the American College of Cardiology.

[596] J. Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Circulation.

[597] R. Dellinger. Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary SyndromesSabatine MS, Morrow DA, Giugliano RP, et al (Brigham and Women's Hosp, Boston; Amgen, Inc, Thousand Oaks, Calif) Circulation 111:2042–2049, 2005§ , 2006 .

[598] S. Chandor. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics , 2006 .

[599] D. Watts,et al. Methamphetamine-induced myocardial infarction with elevated troponin I. , 2006, The American journal of emergency medicine.

[600] N. Rigotti,et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[601] Joseph P Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). , 2006, Journal of the American College of Cardiology.

[602] J. Hollander,et al. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[603] Eugenia Yu,et al. A clinical prediction rule for early discharge of patients with chest pain. , 2006, Annals of emergency medicine.

[604] A. A. Liakishev. [Homocysteine lowering with folic acid and B vitamins in vascular disease]. , 2006, Kardiologiia.

[605] K. Alexander,et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.

[606] A. Liuzzi,et al. A simple tool to predict exercise capacity of obese patients with ischaemic heart disease , 2005, Heart.

[607] E. Fishman,et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. , 2005, American heart journal.

[608] John T Nagurney,et al. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. , 2005, JAMA.

[609] A. Kastrati,et al. Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial , 2005, Circulation.

[610] R. Collins,et al. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[611] D. Berman,et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. , 2005, The New England journal of medicine.

[612] A. Jaffe,et al. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. , 2005, European heart journal.

[613] Sunil V. Rao,et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. , 2005, Journal of the American College of Cardiology.

[614] K. Alexander,et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. , 2005, Journal of the American College of Cardiology.

[615] P. Thompson. Exercise Prescription and Proscription for Patients With Coronary Artery Disease , 2005, Circulation.

[616] C. Cannon,et al. Utilization of catheterization and revascularization procedures in patients with non‐ST segment elevation acute coronary syndrome over the last decade , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[617] W. Henderson,et al. Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina. , 2005, The Annals of thoracic surgery.

[618] L. Goldman,et al. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review , 2005, Canadian Medical Association Journal.

[619] J. Tijssen,et al. Early invasive versus selectively invasive management for acute coronary syndromes. , 2005, The New England journal of medicine.

[620] B. Lewis,et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. , 2005, JAMA.

[621] P. Poole‐Wilson,et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial , 2005, The Lancet.

[622] C. Mullany,et al. Preoperative Aspirin Therapy Is Associated With Improved Postoperative Outcomes in Patients Undergoing Coronary Artery Bypass Grafting , 2005, Circulation.

[623] Patrick W Serruys,et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.

[624] J. Núñez,et al. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score. , 2005, Journal of the American College of Cardiology.

[625] J. Hochman,et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. , 2005, JAMA.

[626] S. Yusuf,et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2005, JAMA.

[627] E. Hylek,et al. Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population. , 2005, Chest.

[628] E. Hannan,et al. Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.

[629] Deepak L. Bhatt,et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. , 2005, The American journal of cardiology.

[630] R. Giugliano,et al. Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes , 2005, Circulation.

[631] G. Stone,et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. , 2005, Journal of the American College of Cardiology.

[632] M. Flather,et al. Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). , 2005, International journal of cardiology.

[633] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[634] L. Newby,et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/Ameri , 2005, Journal of the American College of Cardiology.

[635] P. Gurbel,et al. Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets: Results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) Study , 2005, Circulation.

[636] E. Coleman,et al. Assessing the Quality of Preparation for Posthospital Care from the Patient's Perspective: The Care Transitions Measure , 2005, Medical care.

[637] J. McMurray,et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. , 2005, Journal of the American College of Cardiology.

[638] W. Markiewicz,et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. , 2005, Circulation.

[639] Katherine C. Wu,et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. , 2005, The New England journal of medicine.

[640] B. Maron,et al. Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States , 2005, Circulation.

[641] C Noel Bairey Merz,et al. Angina with "normal" coronary arteries. , 2005 .

[642] M. Lauer,et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Su , 2005, Circulation.

[643] R. Blumenthal,et al. A simplified approach to the management of non-ST-segment elevation acute coronary syndromes. , 2005, JAMA.

[644] R. Bigi,et al. Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial , 2005, Heart.

[645] P. Clemmensen,et al. The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study. , 2004, European heart journal.

[646] Á. Avezum,et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). , 2005, American heart journal.

[647] G. Gross,et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. , 2005, American heart journal.

[648] R. Giugliano,et al. The year in non-ST-segment elevation acute coronary syndromes. , 2005, Journal of the American College of Cardiology.

[649] L. Wallentin,et al. Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction? , 2005, The International Journal of Cardiac Imaging.

[650] R. Califf,et al. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. , 2005, European heart journal.

[651] Deepak L. Bhatt,et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. , 2005, JAMA.

[652] M. Tinetti,et al. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. , 2004, The New England journal of medicine.

[653] Raghava R. Gollapudi,et al. Aspirin sensitivity: implications for patients with coronary artery disease. , 2004, JAMA.

[654] B. Psaty,et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. , 2004, JAMA.

[655] Sunil V. Rao,et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes , 2004 .

[656] H. White,et al. N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes , 2004, Circulation.

[657] C. Cannon,et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes , 2004 .

[658] R. Zietse,et al. Significance of Acute versus Chronic Troponin T Elevation in Dialysis Patients , 2004, Nephron Clinical Practice.

[659] John A. Rumberger,et al. Coronary Artery Calcification and Family History of Premature Coronary Heart Disease: Sibling History Is More Strongly Associated Than Parental History , 2004, Circulation.

[660] Sunil V. Rao,et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[661] B. Lindahl,et al. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. , 2004, American heart journal.

[662] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[663] Holly Rimmasch,et al. Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication Program , 2004, Annals of Internal Medicine.

[664] S. Yusuf,et al. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial , 2004, Circulation.

[665] S. Investigators. Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-Segment elevation acute coronary syndromes managed with an intended early invasive strategy—primary results of the SYNERGY randomized trial☆ , 2004 .

[666] E. Ohman,et al. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[667] E. Topol,et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. , 2004, JAMA.

[668] E. Braunwald,et al. The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with NonST-Segment Elevation Acute Coronary Syndromes , 2004, Annals of Internal Medicine.

[669] David Brieger,et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. , 2004, Chest.

[670] G. Biondi-Zoccai,et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. , 2004, Journal of the American College of Cardiology.

[671] J. Gore,et al. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. , 2004, Archives of internal medicine.

[672] V. Hasselblad,et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. , 2004, JAMA.

[673] R. Ferrari,et al. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. , 2004, Journal of the American College of Cardiology.

[674] R. Califf,et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.

[675] Á. Avezum,et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. , 2004, JAMA.

[676] R. Califf,et al. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. , 2004, American heart journal.

[677] A. Rosengren,et al. Symptoms in acute coronary syndromes: does sex make a difference? , 2004, American heart journal.

[678] L. Shaw,et al. Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[679] G. Levine,et al. Degree of Anticoagulation after One Subcutaneous and One Subsequent Intravenous Booster Dose of Enoxaparin: Implications for Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention , 2004, Journal of Thrombosis and Thrombolysis.

[680] C. Pizzi,et al. Endothelial Function Predicts Future Development of Coronary Artery Disease: A Study of Women With Chest Pain and Normal Coronary Angiograms , 2004, Circulation.

[681] S. Ebrahim,et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.

[682] E. Topol,et al. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). , 2004, The American journal of cardiology.

[683] B. Vladeċk,et al. Risperidone in the Treatment of Elderly Patients with Psychosis of Alzheimer's Disease and Related Dementias , 2004, Journal of the American Geriatrics Society.

[684] B. Chaitman,et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. , 2004, Journal of the American College of Cardiology.

[685] J. Golmard,et al. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes. , 2004, American heart journal.

[686] D. Ramsdale,et al. Effect of completeness of revascularization on clinical outcome in patients with multivessel disease presenting with unstable angina who undergo percutaneous coronary intervention. , 2004, The Journal of invasive cardiology.

[687] W. Peacock,et al. Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy. , 2004, Journal of cardiac failure.

[688] L. Mosca. Heart Disease Prevention in Women , 2004 .

[689] J. Mcanulty. Valsartan, captopril, or both in myocardial infarction. , 2004, The New England journal of medicine.

[690] K. Malmberg,et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. , 2004, Journal of the American College of Cardiology.

[691] K. Eagle,et al. Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes , 2004, Circulation.

[692] I. Palacios,et al. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome , 2004, Heart.

[693] Constance K Haan,et al. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Circulation.

[694] J. Kaski. Pathophysiology and Management of Patients With Chest Pain and Normal Coronary Arteriograms (Cardiac Syndrome X) , 2004, Circulation.

[695] Robert P. Giugliano,et al. Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis In Myocardial Infarction 18) Substudy , 2004, Circulation.

[696] M. Pfeffer,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both , 2004 .

[697] Jack L. Martin,et al. Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[698] B. Chaitman,et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. , 2004, JAMA.

[699] Thomas R. Riley,et al. A Randomized Double-blind Placebo-controlled Trial , 2004 .

[700] L. Mosca. Cardiology patient page. Heart disease prevention in women. American Heart Association. , 2004, Circulation.

[701] Thomas Weber,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[702] Eric J Topol,et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. , 2004, JAMA.

[703] R. Hendersonb,et al. Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction ? The impact of gender in the RITA 3 trial , 2004 .

[704] J. Kaski. Pathophysiology and Management of Patients With Chest Pain and Normal Coronary Arteriograms ( Cardiac Syndrome , 2004 .

[705] W Klein,et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). , 2004, European heart journal.

[706] C. Henrikson,et al. Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease , 2003, Annals of Internal Medicine.

[707] D. Moser,et al. Women’s Early Warning Symptoms of Acute Myocardial Infarction , 2003, Circulation.

[708] M. Yamagishi,et al. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[709] R. Kloner,et al. Time course of the interaction between tadalafil and nitrates. , 2003, Journal of the American College of Cardiology.

[710] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[711] Charles Weissman,et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. , 2003, Journal of the American College of Cardiology.

[712] T. Mcconnell,et al. Clinical Predictors of 30-day Cardiac Events in Patients with Acute Coronary Syndrome at a Community Hospital , 2003, Southern medical journal.

[713] S. Jaglal,et al. Evaluation of a community-based inner-city disease management program for postmyocardial infarction patients: a randomized controlled trial. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[714] Á. Avezum,et al. Predictors of hospital mortality in the global registry of acute coronary events. , 2003, Archives of internal medicine.

[715] S. Yusuf,et al. Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.

[716] A. Jánosi,et al. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF. , 2003, American heart journal.

[717] A. Kastrati,et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[718] E. Ohman,et al. Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2003, Circulation.

[719] Mary Cushman,et al. Estrogen plus progestin and the risk of coronary heart disease. , 2003, The New England journal of medicine.

[720] M. Pfeffer,et al. VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context , 2003, European journal of heart failure.

[721] B. Pitt,et al. Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[722] Fernando Costa,et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.

[723] J. Christenson,et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. , 2003, Journal of the American College of Cardiology.

[724] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[725] J. Richards,et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. , 2003, The Journal of emergency medicine.

[726] H. Sugihara,et al. Assessment ofTakotsubo (ampulla) cardiomyopathy using99mTc-tetrofosmin myocardial SPECT —Comparison with acute coronary syndrome— , 2003, Annals of nuclear medicine.

[727] M. Sabatine,et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. , 2003, Journal of the American College of Cardiology.

[728] E. Coleman. Falling Through the Cracks: Challenges and Opportunities for Improving Transitional Care for Persons with Continuous Complex Care Needs , 2003, Journal of the American Geriatrics Society.

[729] J. Tijssen,et al. Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T. , 2003, Journal of the American College of Cardiology.

[730] E. Topol,et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. , 2003, JAMA.

[731] E. Topol,et al. Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial , 2003, Circulation.

[732] V. Boyko,et al. Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns. , 2003, The American journal of cardiology.

[733] R. Wears,et al. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. , 2003, The American journal of emergency medicine.

[734] E. Braunwald,et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. , 2002, JAMA.

[735] W. Peacock,et al. Cardiac troponins in renal insufficiency: review and clinical implications. , 2002, Journal of the American College of Cardiology.

[736] E. Vicaut,et al. A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention. , 2002, Journal of the American College of Cardiology.

[737] R. Hendel,et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. , 2002, JAMA.

[738] Fred S Apple,et al. Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease , 2002, Circulation.

[739] D. Eterović,et al. Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors. , 2002, American heart journal.

[740] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[741] D. Mangano. Aspirin and mortality from coronary bypass surgery. , 2002, The New England journal of medicine.

[742] S. Steinhubl,et al. Clinical Implications of Percutaneous Coronary Intervention-Clopidogrel in Unstable angina to prevent Recurrent Events (PCI-CURE) Study: A US Perspective , 2002, Circulation.

[743] Furman S. McDonald,et al. Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin i levels. , 2002, The American journal of cardiology.

[744] A. Jaffe,et al. Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.

[745] M. Mcclellan,et al. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[746] E. Braunwald,et al. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. , 2002, Journal of the American College of Cardiology.

[747] C. Cannon,et al. Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes. , 2002, The American journal of cardiology.

[748] K. Fox,et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.

[749] R. Califf,et al. Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes , 2002, Circulation.

[750] E. Funkhouser,et al. Atypical presentations among Medicare beneficiaries with unstable angina pectoris. , 2002, The American journal of cardiology.

[751] R. Hongo,et al. The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting , 2002 .

[752] R. Hongo,et al. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. , 2002, Journal of the American College of Cardiology.

[753] E. Amsterdam,et al. Immediate Exercise Testing to Evaluate Low‐Risk Patients Presenting to the Emergency Department with Chest Pain. , 2002, Journal of the American College of Cardiology.

[754] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[755] D. Grobbee,et al. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial , 2002, The Lancet.

[756] R. Califf,et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. , 2002, The New England journal of medicine.

[757] K. Bailey,et al. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease. , 2002, Mayo Clinic proceedings.

[758] R. Califf,et al. Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Platelet glycoprotein IIB/IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. , 2002, Journal of the American College of Cardiology.

[759] E. Antman,et al. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. , 2002, American heart journal.

[760] Nader Rifai,et al. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide , 2002, Circulation.

[761] E. Braunwald,et al. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial. , 2002, The American journal of cardiology.

[762] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[763] P. Widimsky,et al. Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. , 2002, European heart journal.

[764] E. Antman,et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. , 2002, European heart journal.

[765] R. Califf,et al. Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial , 2002, Circulation.

[766] R. Califf,et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.

[767] J. Ornato,et al. Acute coronary syndromes , 2002 .

[768] Malbea A Lapete,et al. Morbidity and Mortality Weekly Report Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (acip) Centers for Disease Control and Prevention Epidemiology Program Office Early Release 1 Prevention and Control of Influenza Recommendations of the Advis , 2022 .

[769] L. Wallentin,et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. , 2002, Journal of the American College of Cardiology.

[770] Deepak L. Bhatt,et al. Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes , 2001, Circulation.

[771] S. Scolletta,et al. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting. , 2001, The Journal of thoracic and cardiovascular surgery.

[772] E. Braunwald,et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. , 2001, JAMA.

[773] K. Furie,et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.

[774] David A Morrow,et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy , 2001, The Lancet.

[775] M. Sabatine,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.

[776] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[777] M. Ezekowitz,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.

[778] Salim Yusuf,et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.

[779] Peter Libby,et al. Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.

[780] L. Wallentin,et al. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. , 2001, Journal of the American College of Cardiology.

[781] H. Dargie,et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[782] M. Bell,et al. An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery. , 2001, The American journal of cardiology.

[783] F. Verheugt,et al. Oral Anticoagulant Therapy During and After Coronary Angioplasty: The Intensity and Duration of Anticoagulation Are Essential to Reduce Thrombotic Complications , 2001, Circulation.

[784] P. Armstrong,et al. A systematic review of randomized trials of disease management programs in heart failure. , 2001, The American journal of medicine.

[785] S. Steinhubl,et al. Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events: Data From the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial , 2001, Circulation.

[786] S. Yusuf,et al. Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation: Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Study , 2001, Circulation.

[787] G. Montalescot,et al. Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina Pectoris , 2001, Circulation.

[788] P. R. R. Ecurrent,et al. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .

[789] The Esprit investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial , 2000, The Lancet.

[790] S. Connolly,et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[791] J. Birkmeyer,et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. , 2000, The Annals of thoracic surgery.

[792] S. Snapinn,et al. Glycoprotein IIb/IIIa Receptor Blockade Improves Outcomes in Diabetic Patients Presenting With Unstable Angina/Non–ST-Elevation Myocardial Infarction: Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study , 2000, Circulation.

[793] J. Morrison,et al. Cardiac troponin I in pre‐eclampsia and gestational hypertension , 2000, BJOG : an international journal of obstetrics and gynaecology.

[794] A. Siegbahn,et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.

[795] C Cobbaert,et al. Long-term prognostic value of serial troponin T bedside tests in patients with acute coronary syndromes. , 2000, The American journal of cardiology.

[796] R. Harrington,et al. Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy. , 2000, The Annals of thoracic surgery.

[797] R. Califf,et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events. , 2000, Journal of the American College of Cardiology.

[798] A. Jacobs,et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[799] E. Antman,et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[800] F. Menapace,et al. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis. , 2000, American heart journal.

[801] R. Califf,et al. Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. , 2000, The Annals of thoracic surgery.

[802] J. Hollander,et al. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. , 2000, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[803] E. Braunwald,et al. A classification of unstable angina revisited. , 2000, Circulation.

[804] J P Ornato,et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. , 2000, JAMA.

[805] E W Steyerberg,et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.

[806] C. Heeschen,et al. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. , 2000, Journal of the American College of Cardiology.

[807] M Gent,et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[808] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[809] I. Piña,et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endo , 2000, Circulation.

[810] K. Labresh,et al. Get with the guidelines. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[811] H. White,et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban , 1999, The Lancet.

[812] R. Califf,et al. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. , 1999, Circulation.

[813] R. Califf,et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. , 1999, Circulation.

[814] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[815] S. Snapinn,et al. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and s , 1999, Circulation.

[816] E F Cook,et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[817] D Freimark,et al. Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. , 1999, Journal of the American College of Cardiology.

[818] F. Ragmin. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[819] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[820] J S Hochman,et al. A new regimen for heparin use in acute coronary syndromes. , 1999, American heart journal.

[821] B. Davis,et al. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. , 1999, Journal of the American College of Cardiology.

[822] Nick Freemantle,et al. β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .